Michael Byrne

7.6k citations
124 papers · 5.5k indexed · 2 hit papers · h-index 38

Impact in

  • Oncology top 1%
    • Lung Cancer Research Studies
    • Occupational and environmental lung diseases
    • Pleural and Pulmonary Diseases
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Medical Imaging and Pathology Studies

Papers in

    • Breast Cancer Treatment Studies 17
    • Global Cancer Incidence and Screening 15
    • Colorectal Cancer Screening and Detection 6

Michael Byrne

122 papers receiving 5.3k citations

Hit Papers

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer 2006 · 500 citations
5002004202620112018100200300400500

Peers

Michael Byrne
Comparison fields: 5 of 159
  • Oncology 1.9k
  • Pulmonary and Respiratory Medicine 2.1k
  • Cancer Research 553
  • Immunology and Allergy 172
  • Radiology, Nuclear Medicine and Imaging 504
Replace James M. Boyett with:
James M. Boyett United States
T. Tong United States
Konstantinos N. Syrigos Greece
Ferdinand Hofstädter Germany
Rupert Langer Germany
Kohei Akazawa Japan
Si Young Song South Korea
Mark D. Iannettoni United States
Penella J. Woll United Kingdom
Gregory H. Reaman United States
Michael Byrne relative to James M. Boyett United States James M. Boyett's profile →
Citations per field
00.5×1.5×2.0×
James M. Boyett · 1×
Citations per year

Countries citing papers authored by Michael Byrne

Since Specialization
Citations

This map shows the geographic impact of Michael Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Byrne more than expected).

Fields of papers citing papers by Michael Byrne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Byrne. The network helps show where Michael Byrne may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Byrne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Byrne Line = papers co-authored together Michael Byrne links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 201422
3 201361
4 201328
5 201273
6 200821
7 2007151
8 200713
9 200617
10 20045
11
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
Hit paper breakdown →
2004496
12 200249
13 2000141
14 199510
15 1990114
16 198848
17
Deletion of Bleomycin From Therapy for Good Prognosis Advanced Testicular Cancer - a Prospective Randomized Study
198613
18 19836
19 19805
20 19769

About Michael Byrne

Michael Byrne is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 124 papers that have together received 5.5k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (20 papers), Pleural and Pulmonary Diseases (19 papers), Breast Cancer Treatment Studies (17 papers), Global Cancer Incidence and Screening (15 papers), Medical Imaging and Pathology Studies (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Colorectal Cancer Screening and Detection (6 papers) and Testicular diseases and treatments (5 papers). The work is most often cited by research in Oncology (1.9k citations), Pulmonary and Respiratory Medicine (2.1k citations), Cancer Research (553 citations), Immunology and Allergy (172 citations) and Radiology, Nuclear Medicine and Imaging (504 citations). Michael Byrne has collaborated with scholars based in Australia, United States and South Africa. Frequent co-authors include Anna K. Nowak, Arthur W. Musk, Bruce Robinson, Raif S. Geha, Narayanaswamy Ramesh, Val Gebski, Guy van Hazel, Alan S. Coates, John Forbes and Yoji Sasahara. Their work appears in journals such as Journal of Clinical Oncology, Cancer, The Breast, Lung Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026